AllianceBernstein’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.41M | Buy |
27,095
+2,800
| +12% | +$660K | ﹤0.01% | 1501 |
|
|
2026
Q1 | $4.59M | Buy |
24,295
+124
| +0.5% | +$24.5K | ﹤0.01% | 1577 |
|
|
2025
Q4 | $4.57M | Buy |
24,171
+1,918
| +9% | +$369K | ﹤0.01% | 1580 |
|
|
2025
Q3 | $3.94M | Buy |
22,253
+1,576
| +8% | +$234K | ﹤0.01% | 1634 |
|
|
2025
Q2 | $2.35M | Hold |
20,677
| – | – | ﹤0.01% | 1853 |
|
|
2025
Q1 | $2.17M | Buy |
20,677
+31
| +0.2% | +$3.51K | ﹤0.01% | 1847 |
|
|
2024
Q4 | $2.21M | Sell |
20,646
-1,460
| -7% | -$165K | ﹤0.01% | 1908 |
|
|
2024
Q3 | $2.21M | Hold |
22,106
| – | – | ﹤0.01% | 1910 |
|
|
2024
Q2 | $1.86M | Sell |
22,106
-913
| -4% | -$72.7K | ﹤0.01% | 1999 |
|
|
2024
Q1 | $1.68M | Buy |
23,019
+1,460
| +7% | +$108K | ﹤0.01% | 2009 |
|
|
2023
Q4 | $1.54M | Sell |
21,559
-20
| -0.1% | -$1.18K | ﹤0.01% | 2066 |
|
|
2023
Q3 | $1.29M | Hold |
21,579
| – | – | ﹤0.01% | 2108 |
|
|
2023
Q2 | $1.56M | Sell |
21,579
-2,311
| -10% | -$173K | ﹤0.01% | 2039 |
|
|
2023
Q1 | $1.76M | Sell |
23,890
-1,434
| -6% | -$102K | ﹤0.01% | 1939 |
|
|
2022
Q4 | $1.69M | Sell |
25,324
-15,245
| -38% | -$991K | ﹤0.01% | 2018 |
|
|
2022
Q3 | $2.18M | Sell |
40,569
-158
| -0.4% | -$9.29K | ﹤0.01% | 1834 |
|
|
2022
Q2 | $2.27M | Buy |
40,727
+70
| +0.2% | +$3.97K | ﹤0.01% | 1881 |
|
|
2022
Q1 | $2.85M | Buy |
40,657
+199
| +0.5% | +$14.4K | ﹤0.01% | 1880 |
|
|
2021
Q4 | $3.9M | Sell |
40,458
-3,679
| -8% | -$340K | ﹤0.01% | 1755 |
|
|
2021
Q3 | $3.84M | Sell |
44,137
-23,032
| -34% | -$1.78M | ﹤0.01% | 1753 |
|
|
2021
Q2 | $5.5M | Sell |
67,169
-4,745
| -7% | -$395K | ﹤0.01% | 1558 |
|
|
2021
Q1 | $6.84M | Buy |
71,914
+1,310
| +2% | +$124K | ﹤0.01% | 1389 |
|
|
2020
Q4 | $4.38M | Sell |
70,604
-26,551
| -27% | -$1.51M | ﹤0.01% | 1563 |
|
|
2020
Q3 | $5.78M | Sell |
97,155
-10,616
| -10% | -$724K | ﹤0.01% | 1273 |
|
|
2020
Q2 | $7.52M | Sell |
107,771
-1,459
| -1% | -$92.5K | ﹤0.01% | 1123 |
|
|
2020
Q1 | $4.96M | Buy |
109,230
+449
| +0.4% | +$25.4K | ﹤0.01% | 1189 |
|
|
2019
Q4 | $7.08M | Sell |
108,781
-2,773
| -2% | -$185K | ﹤0.01% | 1234 |
|
|
2019
Q3 | $6.93M | Sell |
111,554
-1,924
| -2% | -$121K | ﹤0.01% | 1205 |
|
|
2019
Q2 | $8.08M | Sell |
113,478
-4,889
| -4% | -$360K | 0.01% | 1145 |
|
|
2019
Q1 | $9.28M | Buy |
118,367
+4,536
| +4% | +$344K | 0.01% | 1090 |
|
|
2018
Q4 | $9.64M | Buy |
113,831
+39,437
| +53% | +$4.2M | 0.01% | 1008 |
|
|
2018
Q3 | $12.7M | Sell |
74,394
-481
| -0.6% | -$72.5K | 0.01% | 911 |
|
|
2018
Q2 | $9.68M | Buy |
74,875
+1,555
| +2% | +$174K | 0.01% | 980 |
|
|
2018
Q1 | $7.55M | Sell |
73,320
-513
| -0.7% | -$50.7K | 0.01% | 1027 |
|
|
2017
Q4 | $6.31M | Hold |
73,833
| – | – | ﹤0.01% | 1113 |
|
|
2017
Q3 | $6.27M | Hold |
73,833
| – | – | ﹤0.01% | 1112 |
|
|
2017
Q2 | $5.59M | Buy |
73,833
+12,279
| +20% | +$859K | ﹤0.01% | 1157 |
|
|
2017
Q1 | $4.06M | Buy |
61,554
+9,602
| +18% | +$632K | ﹤0.01% | 1318 |
|
|
2016
Q4 | $3.29M | Hold |
51,952
| – | – | ﹤0.01% | 1471 |
|
|
2016
Q3 | $3.31M | Hold |
51,952
| – | – | ﹤0.01% | 1394 |
|
|
2016
Q2 | $3.87M | Buy |
51,952
+7,374
| +17% | +$547K | ﹤0.01% | 1197 |
|
|
2016
Q1 | $2.98M | Sell |
44,578
-5,129
| -10% | -$312K | ﹤0.01% | 1328 |
|
|
2015
Q4 | $3.36M | Sell |
49,707
-6,012
| -11% | -$371K | ﹤0.01% | 1249 |
|
|
2015
Q3 | $2.98M | Sell |
55,719
-6,460
| -10% | -$392K | ﹤0.01% | 1348 |
|
|
2015
Q2 | $3.91M | Sell |
62,179
-1,603
| -3% | -$87.5K | ﹤0.01% | 1250 |
|
|
2015
Q1 | $3.07M | Hold |
63,782
| – | – | ﹤0.01% | 1426 |
|
|
2014
Q4 | $2.12M | Hold |
63,782
| – | – | ﹤0.01% | 1718 |
|
|
2014
Q3 | $1.87M | Hold |
63,782
| – | – | ﹤0.01% | 1774 |
|
|
2014
Q2 | $2.48M | Sell |
63,782
-168
| -0.3% | -$6.82K | ﹤0.01% | 1614 |
|
|
2014
Q1 | $2.68M | Buy |
63,950
+9,607
| +18% | +$400K | ﹤0.01% | 1493 |
|
|
2013
Q4 | $1.78M | Sell |
54,343
-3,036
| -5% | -$98.9K | ﹤0.01% | 1802 |
|
|
2013
Q3 | $1.55M | Sell |
57,379
-3,719
| -6% | -$105K | ﹤0.01% | 1866 |
|
|
2013
Q2 | $1.43M | Buy |
+61,098
| New | +$1.1M | ﹤0.01% | 1854 |
|
Other funds holding LGND
JT
CAM
AllianceBernstein's LGND Position: Q2 2026 in Review
AllianceBernstein increased its Ligand Pharmaceuticals (LGND) stake by 12% in Q2 2026, buying an estimated $660K and bringing the position to 27,095 shares worth $5.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1501.
AllianceBernstein first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.7M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- AllianceBernstein held 27,095 shares of Ligand Pharmaceuticals worth $5.41M as of Q2 2026.
- AllianceBernstein bought 2,800 Ligand Pharmaceuticals shares in Q2 2026, an estimated $660K.
- Ligand Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1501 holding.
- AllianceBernstein first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- AllianceBernstein's Ligand Pharmaceuticals position peaked at $12.7M in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.